485 related articles for article (PubMed ID: 17675616)
1. Management of transjugular intrahepatic portosystemic shunt induced refractory hepatic encephalopathy with the parallel technique: results of a clinical follow-up study.
Maleux G; Heye S; Verslype C; Nevens F
J Vasc Interv Radiol; 2007 Aug; 18(8):986-92; quiz 993. PubMed ID: 17675616
[TBL] [Abstract][Full Text] [Related]
2. Outcome of 100 patients after transjugular intrahepatic portosystemic shunt for variceal hemorrhage.
Sahagun G; Benner KG; Saxon R; Barton RE; Rabkin J; Keller FS; Rosch J
Am J Gastroenterol; 1997 Sep; 92(9):1444-52. PubMed ID: 9317060
[TBL] [Abstract][Full Text] [Related]
3. A modified procedure for transjugular intrahepatic portosystemic shunt flow reduction.
Jacquier A; Vidal V; Monnet O; Varoquaux A; Gaubert JY; Champsaur P; Gerolami R; Bartoli JM; Moulin G
J Vasc Interv Radiol; 2006 Aug; 17(8):1359-63. PubMed ID: 16923985
[TBL] [Abstract][Full Text] [Related]
4. Transjugular intrahepatic portosystemic shunts in liver transplant recipients for management of refractory ascites: clinical outcome.
Saad WE; Darwish WM; Davies MG; Waldman DL
J Vasc Interv Radiol; 2010 Feb; 21(2):218-23. PubMed ID: 20123207
[TBL] [Abstract][Full Text] [Related]
5. Transjugular intrahepatic portosystemic shunt flow reduction with adjustable polytetrafluoroethylene-covered balloon-expandable stents.
Kroma G; Lopera J; Cura M; Suri R; El-Merhi F; Reading J
J Vasc Interv Radiol; 2009 Jul; 20(7):981-6. PubMed ID: 19497763
[TBL] [Abstract][Full Text] [Related]
6. Transjugular intrahepatic portosystemic stent shunt (TIPSS) modification in the management of post-TIPSS refractory hepatic encephalopathy.
Kochar N; Tripathi D; Ireland H; Redhead DN; Hayes PC
Gut; 2006 Nov; 55(11):1617-23. PubMed ID: 16571635
[TBL] [Abstract][Full Text] [Related]
7. Endovascular shunt reduction in the management of transjugular portosystemic shunt-induced hepatic encephalopathy: preliminary experience with reduction stents and stent-grafts.
Maleux G; Verslype C; Heye S; Wilms G; Marchal G; Nevens F
AJR Am J Roentgenol; 2007 Mar; 188(3):659-64. PubMed ID: 17312051
[TBL] [Abstract][Full Text] [Related]
8. Management of transjugular intrahepatic portosystemic shunt (TIPS)-associated refractory hepatic encephalopathy by shunt reduction using the parallel technique: outcomes of a retrospective case series.
Cookson DT; Zaman Z; Gordon-Smith J; Ireland HM; Hayes PC
Cardiovasc Intervent Radiol; 2011 Feb; 34(1):92-9. PubMed ID: 21057793
[TBL] [Abstract][Full Text] [Related]
9. Transjugular intrahepatic portosystemic shunts in hemodialysis-dependent patients and patients with advanced renal insufficiency: safety, caution, and encephalopathy.
Haskal ZJ; Radhakrishnan J
J Vasc Interv Radiol; 2008 Apr; 19(4):516-20. PubMed ID: 18375295
[TBL] [Abstract][Full Text] [Related]
10. ePTFE-covered stent-grafts for revision of obstructed transjugular intrahepatic portosystemic shunt.
Cejna M; Peck-Radosavljevic M; Thurnher S; Schoder M; Rand T; Angermayr B; Lammer J
Cardiovasc Intervent Radiol; 2002; 25(5):365-72. PubMed ID: 11981612
[TBL] [Abstract][Full Text] [Related]
11. The role of transjugular intrahepatic portosystemic shunt (TIPS) in the management of portal hypertension.
Colombato L
J Clin Gastroenterol; 2007; 41 Suppl 3():S344-51. PubMed ID: 17975487
[TBL] [Abstract][Full Text] [Related]
12. Comparison of transjugular intrahepatic portosystemic shunt dysfunction in PTFE-covered stent-grafts versus bare stents.
Barrio J; Ripoll C; Bañares R; Echenagusia A; Catalina MV; Camúñez F; Simó G; Santos L
Eur J Radiol; 2005 Jul; 55(1):120-4. PubMed ID: 15950109
[TBL] [Abstract][Full Text] [Related]
13. Transjugular intrahepatic portosystemic shunt in the treatment of portal hypertension using memotherm stents: a prospective multicenter study.
Domagk D; Patch D; Dick R; Grosso M; Rousseau H; Otal P; Goffette P; Heinecke A; Drees M; Domschke W; Menzel J
Cardiovasc Intervent Radiol; 2002; 25(6):506-12. PubMed ID: 12183763
[TBL] [Abstract][Full Text] [Related]
14. Results of a retrospective multicenter trial of the Viatorr expanded polytetrafluoroethylene-covered stent-graft for transjugular intrahepatic portosystemic shunt creation.
Charon JP; Alaeddin FH; Pimpalwar SA; Fay DM; Olliff SP; Jackson RW; Edwards RD; Robertson IR; Rose JD; Moss JG
J Vasc Interv Radiol; 2004 Nov; 15(11):1219-30. PubMed ID: 15525740
[TBL] [Abstract][Full Text] [Related]
15. Portosystemic hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in patients with cirrhosis: clinical, laboratory, psychometric, and electroencephalographic investigations.
Nolte W; Wiltfang J; Schindler C; Münke H; Unterberg K; Zumhasch U; Figulla HR; Werner G; Hartmann H; Ramadori G
Hepatology; 1998 Nov; 28(5):1215-25. PubMed ID: 9794904
[TBL] [Abstract][Full Text] [Related]
16. A novel endovascular adjustable polytetrafluoroethylene-covered stent for the management of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt.
Weintraub JL; Mobley DG; Weiss ME; Swanson E; Kothary N
J Vasc Interv Radiol; 2007 Apr; 18(4):563-6. PubMed ID: 17446548
[TBL] [Abstract][Full Text] [Related]
17. Hepatic encephalopathy after transjugular intrahepatic portosystemic shunt.
Riggio O; Nardelli S; Moscucci F; Pasquale C; Ridola L; Merli M
Clin Liver Dis; 2012 Feb; 16(1):133-46. PubMed ID: 22321469
[TBL] [Abstract][Full Text] [Related]
18. [Treatment of refractory hepatic encephalopathy associated with insertion of a transjugular intrahepatic portosystemic shunt through new endovascular techniques: a case report].
Martínez Moreno B; Bellot P; de España F; Palazón JM; Such J; Pérez-Mateo M
Gastroenterol Hepatol; 2011; 34(7):468-73. PubMed ID: 21652116
[TBL] [Abstract][Full Text] [Related]
19. Is sonographic surveillance of polytetrafluoroethylene-covered transjugular intrahepatic portosystemic shunts (TIPS) necessary? A single centre experience comparing both types of stents.
Pan JJ; Chen C; Geller B; Firpi R; Machicao VI; Caridi JG; Nelson DR; Morelli G
Clin Radiol; 2008 Oct; 63(10):1142-8. PubMed ID: 18774362
[TBL] [Abstract][Full Text] [Related]
20. Portosystemic pressure gradient during transjugular intrahepatic portosystemic shunt with Viatorr stent graft: what is the critical low threshold to avoid medically uncontrolled low pressure gradient related complications?
Chung HH; Razavi MK; Sze DY; Frisoli JK; Kee ST; Dake MD; Hellinger JC; Kang BC
J Gastroenterol Hepatol; 2008 Jan; 23(1):95-101. PubMed ID: 18171347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
